EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

 ISSN 2394-3211

Impact Factor: 7.065

 ICV - 79.57

Abstract

A STUDY ON KNOWLEDGE, AWARENESS & ATTITUDE ABOUT MUCORMYCOSIS AMONG MEDICAL STUDENTS IN INDIA.

Kathar Meghana Ramakant, Arunadevi Chinnadurai and Srabani Bhattacharya*

ABSTRACT

This Cross- Sectional Study was conducted among medical Students of either gender who had taken admission in different medical colleges of Maharashtra State, India. The age of the participants were 18+ yrs. Total number of participant were 108. Among them 57.4% male & 42.6%. female. 78.7% Were form Urban area & 21-3% from rural area. 17% of the participants tested COVID-19 positive 13% of the participants done Chest CT. Among them 4%. Check iron level once in 6 months, 17%. once in a year & 79% never checked iron level. None of the participants were under Chemo & Steroid therapy. Regarding the treatment of Covid 19 8.3% aware Completely, 81.5% were completely unaware. The answer regarding the treatment used for COVID-19, the respondants answered 89.8%drugs like Ramdesivir, 75.9% Plasma therapy & 64.8% Corticosteroids. Regarding the awareness about post Covid Complications 96.3% answered mucormycosis, 66.7% Fibrosis of Lungs. Regarding the awareness. about black & while fungal diseases 99% answered Yes. 76.9% of the respondants were aware about symptoms of mucormycosis. Regarding their awareness about the precautions 88% answeard about the personal hygiene, 73.1% avoid activities that involve close contact, 63% to Control diabetes 77.84% to wear gloves when handling soil* 59.3% to wear N95 respirator. Their awareness about diagnostic methods wear 65.7% fungal Culture, 52.8% Laboratory microscopy, 49.1%tissue biopsies and endoscopy, 30.6% CT&MRI. Thein awareness regarding build up immunity 86.1% agreed for personal hygiene, 88.9% exercise regularly, 85.2% get vaccinated, 90.7%. Consume Vitamin C enriched food.

Keywords: Mucormycosis, Awareness, Treatment.


[Full Text Article] [Download Certificate]

Citation

  All Since 2019
 Citation  3086  2560
 h-index  18  17
 i10-index  64  44

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 November 2024 Issue has been Published, Kindly check it on https://www.ejpmr.com/issue

  • EJPMR: NOVEMBER ISSUE PUBLISHED

    NOVEMBER 2024 issue has been successfully launched on NOVEMBER 2024.

  • EJPMR New Impact Factor

    EJPMR Impact Factor has been Increased to 7.065 for Year 2024.

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database Academia

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along witcertificate to promote resear activity of scholar.

Best Article of current issue :

Dr. Kartik Neog
Download Article : Click here